NCT01525420
Completed
Not Applicable
Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy
ConditionsSmoking
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Smoking
- Sponsor
- Fred Hutchinson Cancer Center
- Enrollment
- 121
- Locations
- 1
- Primary Endpoint
- Number of Participants Who Stopped Smoking by 6 Month Post Treatment
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).
Implementation outcomes:
- end of treatment and 6-month follow-up data retention rates;
- intervention implementation quality;
- number & length of calls completed.
Comparison of each arm's implementation
Investigators
Jonathan Bricker
Associate Member, Public Health Sciences
Fred Hutchinson Cancer Center
Eligibility Criteria
Inclusion Criteria
- •aged 18 and older;
- •smokes at least 10 cigarettes daily and has done so for at least the past 12 months;
- •wants to quit smoking in the next 30 days;
- •willing to be randomly assigned to either group;
- •willing and able to speak and read in English;
- •willing and medically eligible to use nicotine replacement therapy (NRT),
- •currently resides in the U.S., and expects to continue for at least 12 months;
- •not participating in other smoking cessation interventions;
- •has regular access to a telephone.
- •has regular access to an email address.
Exclusion Criteria
- •The Exclusion criteria are the opposite of the Inclusion criteria listed above. In addition, the following exclusion criteria also apply:
- •another member of household enrolled in the study;
- •currently using medication or nicotine replacement products to help with quitting smoking;
- •currently using any non-cigarette tobacco products;
- •pregnant or breastfeeding;
- •had a heart attack in last 30 days;
- •within the last 6 months, diagnosed with angina, heart pain, or irregular heartbeat;
- •serious adverse reactions to nicotine patches including anaphylaxis and related symptoms such as hives, respiratory difficulty, and/or angioedema.
Outcomes
Primary Outcomes
Number of Participants Who Stopped Smoking by 6 Month Post Treatment
Time Frame: 6 months
30-Day point prevalence abstinence at 6 months post treatment
Secondary Outcomes
- 7-day and 24-hour Point Prevalence Quit Rates(6-month)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Telephone-Delivered Interventions for Smoking CessationSmokingNCT02421991Fred Hutchinson Cancer Center1,275
Completed
Not Applicable
Yoga for Men Attempting Smoking CessationSmoking CessationNCT02055326The Miriam Hospital38
Completed
Phase 1
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung CancerStage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerTobacco Use DisorderNCT01457469Wake Forest University Health Sciences6
Completed
Phase 4
UW-CTRI Triple Medication Smoking Cessation StudySmokingNCT02681510University of Wisconsin, Madison36
Completed
Not Applicable
Offering Proactive Tobacco TreatmentTobacco Use CessationNCT01123967University of Minnesota2,500